Product Portfolio

Antimicrobial resistance

Protecting medical progress and supporting more appropriate antibiotic therapy

Antimicrobial resistance is an ever-evolving threat to human health—stemming from the widespread and inappropriate use of antibiotics.

Diagnosing infections based on the presentation of clinical signs and symptoms may result in antibiotics being inappropriately prescribed.1 The ability to generate confident results quickly can enable earlier initiation of appropriate treatment if treatment is required at all.

Roche’s diagnostic portfolio allows for the adoption of different strategies to cover a range of scenarios—from detecting pathogens early for decreased transmission risk to supporting antimicrobial stewardship efforts.

View products


  1. World Health Organization. Antibiotic prescribing and resistance: Views from low- and middle-income prescribing and dispensing professionals. Accessed May 26, 2021.
Found 0 results in